Structure-based design and synthesis of 2,4-diaminopyrimidines as EGFR L858R/T790M selective inhibitors for NSCLC.
Chen L, Fu W, Feng C, Qu R, Tong L, Zheng L, Fang B, Qiu Y, Hu J, Cai Y, Feng J, Xie H, Ding J, Liu Z, Liang G.
Chen L, et al. Among authors: feng j, feng c.
Eur J Med Chem. 2017 Nov 10;140:510-527. doi: 10.1016/j.ejmech.2017.08.061. Epub 2017 Sep 20.
Eur J Med Chem. 2017.
PMID: 28987609